Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Chinese Biotech Sinovac Gets OK on Flu Vaccine

By Pharmaceutical Processing | August 31, 2009

NEW YORK (AP) — Chinese biopharmaceutical Sinovac Biotech Ltd. shares hit a record high on Monday after the company said experts from China’s drug regulator had approved its swine flu vaccine, and it expected to get a production license within one week. Shares of Sinovac jumped $1.53, or 24 percent, to $7.85 in morning trading. They peaked earlier at $7.94, their highest since trading as a public company began in 2003, on more than ten times normal volume. The company said an experts evaluation by the State Food and Drug Administration, China’s food and drug regulator, had unanimously passed its swine flu vaccine. Sinovac expects to get a production license this week after the panel submits its approval to the SFDA. Sinovac earlier this month completed a clinical trial of its swine flu vaccine, which the company said showed “good immunogenicity,” meaning it is capable of provoking an immune system response to swine flu, in a single shot. Sinovac said then it was the first company in the world to complete testing of a vaccine for the flu strain. Sinovac is known in China as Beijing Kexing Bioproducts, and specializes in developing vaccines for infectious diseases such as hepatitis A and B, influenza and SARS, or severe acute respiratory syndrome.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE